CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes. - Test2 - elhamkhani - TriplyDB

CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.

CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.

http://www.wikidata.org/entity/Q33916537

about

CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.

http://www.wikidata.org/entity/Q33916537

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

CD36 overexpression: a possibl ...... with prediabetes and diabetes.

@ast

CD36 overexpression: a possibl ...... with prediabetes and diabetes.

@en

type

label

CD36 overexpression: a possibl ...... with prediabetes and diabetes.

@ast

CD36 overexpression: a possibl ...... with prediabetes and diabetes.

@en

prefLabel

CD36 overexpression: a possibl ...... with prediabetes and diabetes.

@ast

CD36 overexpression: a possibl ...... with prediabetes and diabetes.

@en

P1433

Q33916537-4084781D-E634-4A60-8A47-B408F599B505

P1476

Q33916537-53B1285C-7F3A-4342-A45E-D8C30EC6032A

P2093

Q33916537-23459152-EC57-45C5-8076-5CB75488C552

Q33916537-42022DFE-2629-4C37-8645-11450D0F8CE2

Q33916537-9290EE15-051E-45D2-A7F5-FD1DAF143218

Q33916537-A2920EA5-4A76-4463-940B-0D76C7DFA09C

Q33916537-AEEF607E-0230-4D99-8B5C-638C77FB05B8

Q33916537-EE11D1E3-6EF0-401B-830F-11BF5CB0DE81

P2860

Q33916537-049FA8B2-47A1-4AB9-A424-786F603DED72

Q33916537-1275F03C-97C8-429A-97A4-A0B4A20E8F41

Q33916537-19011E76-A3A3-438D-AB6A-EB7B26EC9BA9

Q33916537-194E4A37-89FF-40E0-A3E6-2397FF8190C7

Q33916537-1F7AFE87-DA80-4394-AA73-84DF1637BDB5

Q33916537-216C28F6-8339-4AB3-A582-08704CE8C42A

Q33916537-3438D91C-E765-4CA5-BE30-9F737F53FB83

Q33916537-34EC0EF6-EB72-4E0D-8ADA-EDC19E84047A

Q33916537-3B0485AF-E4AD-4D2C-AA19-A61737944391

Q33916537-3FBB2C0E-CD45-49C4-B5C2-CDDB1DAFE31D

P2888

Q33916537-6D0DCCAB-65ED-4E40-8AEF-386E56A6B7AC

P304

Q33916537-ED5D26AB-5104-4478-B1DF-FAA171CDAC52

P31

Q33916537-A0CC59FA-6FC1-454A-A670-547A8D3539D8

P356

Q33916537-FE6B61E9-36C5-482E-83A6-EB07F33F7FFF

P478

Q33916537-2ECA279A-D3EC-4FFA-9F25-2D2C6096F9E8

P577

Q33916537-C74EE2B9-674E-47F9-AD24-4896E0E50673

P6179

Q33916537-94686EDE-793B-4144-9B6E-7F1D0302A9EF

P698

Q33916537-B8A0EAD1-E80A-4CCE-A5FE-7C2E317468C6

P921

Q33916537-1A09E72F-3207-4F5C-BB67-446453782033

Q33916537-3BE15D10-8BAC-4DB3-8AAB-32E7BFB93EA2

P932

Q33916537-8CFE69FD-05CD-4ECC-B7AC-3A98F8BD7214

P356

S13098-017-0253-X

P1433

Diabetology and Metabolic Syndrome

P1476

CD36 overexpression: a possibl ...... with prediabetes and diabetes.

@en

P2093

A Vargas-Candela

http://www.w3.org/2001/XMLSchema#string

F J Tinahones

http://www.w3.org/2001/XMLSchema#string

M C Plaza-Seron

http://www.w3.org/2001/XMLSchema#string

M D Lopez-Carmona

http://www.w3.org/2001/XMLSchema#string

M R Bernal-Lopez

http://www.w3.org/2001/XMLSchema#string

R Gomez-Huelgas

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction

Executive summary: Standards of medical care in diabetes--2010

Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy

Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels

Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia

Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes.

P2888

s13098-017-0253-x

P304

55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13098-017-0253-X

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090742896

http://www.w3.org/2001/XMLSchema#string

P698

28729885

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5516302

http://www.w3.org/2001/XMLSchema#string